Addyi, the first and only FDA-approved pill clinically proven to treat frustrating low sexual desire in women, is now approved for use in women who have gone through menopause RALEIGH, N.C., Dec. 15, 2025 /PRNewswire/ -- Sprout Pharmaceuticals today announced a monumental milestone for...
Hence then, the article about historic first in women s sexual health fda grants approval for addyi flibanserin in postmenopausal women was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Historic First in Women's Sexual Health: FDA Grants Approval for Addyi® (flibanserin) in Postmenopausal Women )
Also on site :
- Radha Exports partners with Körber for advanced warehouse automation in Singapore
- Linda Evangelista paid $1.4 million in 2001 for a Chelsea penthouse with a 2,500-square-foot roof terrace; 25 years later she sold it for $6.75 million
- In 1974, three artists buried 10 Cadillacs nose-first in an Amarillo, Texas wheat field; the row was moved 2 miles west in 1997 as the city grew